Oramed Pharmaceuticals Inc Cash Flow Reinvestment Rate
Oramed Pharmaceuticals Inc cash flow reinvestment rate. Oramed Pharmaceuticals Inc (ORMP) has a Cash Flow Reinvestment Rate of 45.70x as of June 2024, reinvesting $94.66 Million (capex $17.06 plus investments $94.66 Million) from operating cash flow of $2.07 Million. Explore ORMP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Oramed Pharmaceuticals Inc (2016–2016)
Cash flow reinvestment rate of Oramed Pharmaceuticals Inc from 2016 to 2016. Historical reinvestment intensity for Oramed Pharmaceuticals Inc across 1 annual periods. Explore ORMP capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Oramed Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2016–2016)
Oramed Pharmaceuticals Inc cash flow reinvestment rate by year from 2016 to 2016. Year-by-year capital reinvestment analysis for Oramed Pharmaceuticals Inc. For the full cash flow conversion analysis, see Oramed Pharmaceuticals Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.00x | $9.00K | $4.66 Million | $9.00K | — |